| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.98B | 2.77B | 2.63B | 2.80B | 3.21B | 3.03B |
| Gross Profit | 1.23B | 1.46B | 1.04B | 1.47B | 1.86B | 2.29B |
| EBITDA | 252.66M | 191.71M | 6.81M | 500.96M | -1.84B | -483.18M |
| Net Income | 446.94M | 367.51M | 167.22M | 607.72M | -1.57B | -663.87M |
Balance Sheet | ||||||
| Total Assets | 6.52B | 6.45B | 6.15B | 5.92B | 5.25B | 4.71B |
| Cash, Cash Equivalents and Short-Term Investments | 1.66B | 2.60B | 3.39B | 3.70B | 2.79B | 2.26B |
| Total Debt | 79.81M | 243.92M | 197.76M | 14.05M | 58.59M | 64.26M |
| Total Liabilities | 1.51B | 1.58B | 1.47B | 1.16B | 1.28B | 1.52B |
| Stockholders Equity | 5.01B | 4.80B | 4.59B | 4.77B | 3.97B | 3.18B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 218.84M | 392.99M | 753.82M | -1.13B | -803.82M |
| Operating Cash Flow | 0.00 | 437.25M | 406.52M | 765.71M | -1.10B | -777.11M |
| Investing Cash Flow | 0.00 | 291.64M | -1.17B | -139.82M | -846.90M | -1.22B |
| Financing Cash Flow | 0.00 | -198.58M | -377.24M | -57.46M | 2.12B | 2.05B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $1.13B | 9.25 | 18.68% | 4.00% | 0.76% | ― | |
75 Outperform | $895.29M | 2.23 | 82.04% | ― | ― | ― | |
74 Outperform | $683.54M | 9.85 | 10.39% | 2.12% | 18.70% | 62.14% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
59 Neutral | $2.77B | 66.04 | ― | ― | 24.81% | 55.93% | |
57 Neutral | $2.06B | -381.17 | -0.57% | 2.55% | 11.71% | -101.08% | |
40 Underperform | $120.31M | -0.29 | -7.90% | ― | -42.13% | -797.10% |
On December 3, 2025, Waterdrop Inc. announced its unaudited financial results for the third quarter of 2025, showcasing substantial growth. The company reported a significant year-over-year increase in operating profit and net profit, driven by a 38.4% rise in net operating revenue. Insurance-related income saw a 44.8% increase, and the company expanded its medical crowdfunding and clinical trial services. Waterdrop’s advancements in AI technology have enhanced its operational efficiency, contributing to a 32.3% sequential increase in insurance premiums. The company also focused on improving transparency and fraud detection in its crowdfunding services, while expanding its collaboration network in clinical trials, leading to a 31.3% rise in related revenue. Waterdrop’s strategic initiatives and AI integration are expected to continue driving business momentum and delivering value to shareholders.
On December 2, 2025, Waterdrop Inc. announced significant changes in its board and management composition. Mr. Guang Yang resigned from his roles as director, vice president of finance, and general manager of international business due to personal reasons. Ms. Xiaolei Sun was appointed as a new director, while Ms. Jieru Li took over as vice president of finance, responsible for accounting and financial matters. These changes are expected to bring new perspectives and strengthen the company’s strategic and financial operations.